Agilent Technologies, Inc. $A Stock Position Lifted by Aberdeen Group plc

Aberdeen Group plc grew its position in shares of Agilent Technologies, Inc. (NYSE:A) by 10.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 292,661 shares of the medical research company’s stock after buying an additional 26,625 shares during the quarter. Aberdeen Group plc’s holdings in Agilent Technologies were worth $34,537,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Stone House Investment Management LLC acquired a new stake in Agilent Technologies in the 1st quarter worth approximately $30,000. Opal Wealth Advisors LLC acquired a new stake in Agilent Technologies in the 1st quarter valued at approximately $31,000. Ransom Advisory Ltd bought a new position in Agilent Technologies in the 1st quarter worth approximately $32,000. Central Pacific Bank Trust Division bought a new stake in Agilent Technologies in the 2nd quarter valued at $33,000. Finally, Zions Bancorporation National Association UT acquired a new stake in Agilent Technologies in the 1st quarter worth $38,000.

Agilent Technologies Stock Down 2.5%

NYSE:A opened at $136.62 on Monday. The stock has a market cap of $38.73 billion, a price-to-earnings ratio of 32.07, a PEG ratio of 4.46 and a beta of 1.26. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a 50-day moving average price of $125.04 and a two-hundred day moving average price of $117.02. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Analyst Ratings Changes

Several research firms have recently weighed in on A. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Barclays increased their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday, October 2nd. Robert W. Baird upped their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. lifted their target price on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $148.69.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.